Clinical Trials Browser

Phase 3 × Interferon alpha-2 × Lymphoid × Clear all

NCT01609010 2014-09-08

A Study of MabThera/Rituxan (Rituximab) Alone and in Combination With Roferon-A in Patients With Follicular or Other CD20+ Low-Grade (Indolent) Lymphoma

Phase 3 Completed

313 enrolled 15 charts

Lymphoma